BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21386845)

  • 1. Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma.
    Horikawa T; Yoshizaki T; Kondo S; Furukawa M; Kaizaki Y; Pagano JS
    Br J Cancer; 2011 Mar; 104(7):1160-7. PubMed ID: 21386845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
    Horikawa T; Yang J; Kondo S; Yoshizaki T; Joab I; Furukawa M; Pagano JS
    Cancer Res; 2007 Mar; 67(5):1970-8. PubMed ID: 17332324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
    Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
    Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis.
    Chou YC; Chen CL; Yeh TH; Lin SJ; Chen MR; Doong SL; Lu J; Tsai CH
    Am J Pathol; 2012 Nov; 181(5):1773-81. PubMed ID: 22974584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
    Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
    Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells.
    Li R; Zhao Y; Chen J; Shao S; Zhang X
    Mol Med Rep; 2014 Feb; 9(2):413-8. PubMed ID: 24297333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
    Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes.
    Aga M; Bentz GL; Raffa S; Torrisi MR; Kondo S; Wakisaka N; Yoshizaki T; Pagano JS; Shackelford J
    Oncogene; 2014 Sep; 33(37):4613-22. PubMed ID: 24662828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.
    Xu J; Deng X; Tang M; Li L; Xiao L; Yang L; Zhong J; Bode AM; Dong Z; Tao Y; Cao Y
    PLoS One; 2013; 8(3):e56114. PubMed ID: 23472069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells.
    Li G; Wu Z; Peng Y; Liu X; Lu J; Wang L; Pan Q; He ML; Li XP
    Cancer Lett; 2010 Dec; 299(1):29-36. PubMed ID: 20732742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.
    Lui VW; Yau DM; Cheung CS; Wong SC; Chan AK; Zhou Q; Wong EY; Lau CP; Lam EK; Hui EP; Hong B; Hui CW; Chan AS; Ng PK; Ng YK; Lo KW; Tsang CM; Tsui SK; Tsao SW; Chan AT
    Oncogene; 2011 Mar; 30(13):1518-30. PubMed ID: 21119603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction.
    Lin Z; Wan X; Jiang R; Deng L; Gao Y; Tang J; Yang Y; Zhao W; Yan X; Yao K; Sun B; Chen Y
    J Virol; 2014 Oct; 88(20):11872-85. PubMed ID: 25100829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
    Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
    PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells.
    Wang L; Tian WD; Xu X; Nie B; Lu J; Liu X; Zhang B; Dong Q; Sunwoo JB; Li G; Li XP
    Cancer; 2014 Feb; 120(3):363-72. PubMed ID: 24190575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
    Zhang J; Jia L; Liu T; Yip YL; Tang WC; Lin W; Deng W; Lo KW; You C; Lung ML; Lung HL; Cheung AL; Tsao SW; Tsang CM
    Oncogene; 2019 Jun; 38(24):4669-4684. PubMed ID: 30745576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
    Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
    PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.